An Ad5-Vectored HIV-1 Vaccine Elicits Cell-mediated Immunity but does not Affect Disease Progression in HIV-1-infected Male Subjects: Results From a Randomized Placebo-Controlled Trial (The Step Study)

Background. The Step study was a randomized trial to determine whether an adenovirus type 5 (Ad5) vector vaccine, which elicits T cell immunity, can lead to control of human immunodeficiency virus (HIV) replication in participants who became HIV-infected after vaccination. Methods. We evaluated the...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 203; no. 6; pp. 765 - 772
Main Authors Fitzgerald, D. W., Janes, H., Robertson, M., Coombs, R., Frank, I., Gilbert, P., Loufty, M., Mehrotra, D., Duerr, A.
Format Journal Article
LanguageEnglish
Published Oxford Oxford University Press 15.03.2011
Subjects
Online AccessGet full text

Cover

Loading…